Linnea®
Butylscopolamine

 

PLANT

Duboisia

PART OF THE PLANT USED

Leaves

APPEARANCE

White or almost white Crystalline powder

CAS NUMBER

149-64-4

Linnea® Butylscopolamine


A peripherally-acting antimuscarinic and anticholinergic agent, Linnea has produced pharmaceutical grade Butylscopolamine in its manufacturing facilities since 1985, obtaining this semi-synthetic derivative from the leaves of the Duboisia plant.

Uses

Pharmaceutical

• Smooth muscles spasms
• Renal colic pain
• Dysmenorrhea
• Irritable bowel syndrome

Products

Pharmaceutical

BUTYLSCOPOLAMINE ORAL GRADE
SUITABLE FOR ORAL PHARMACEUTICAL FORMS
Semi-synthetic derivative
HYJECT™ BUTYLSCOPOLAMINE
SUITABLE FOR INJECTABLE
Semi-synthetic derivative

Non-sterile suitable for injectable pharmaceutical forms

Features

Complies with Ph. Eur. “Hyoscine butylbromide” monograph, current edition

The logo indicates that Linnea is CEP certified for producing butylscopolamine. CEP stands for Certificate of Suitability.

CEP

The logo indicates that Linnea is compliant with the European Pharmacopoeia standards for producing butylscopolamine ingredients.

Ph. Eur.

The logo indicates that Linnea Natural Pharma Solutions has created a DMF for producing butylscopolamine. DMF stands for Drug Master Files which details information about the manufacturing processes of Linnea.

DMF

The logo indicates that, while producing butylscopolamine, Linnea’s facility remains GMP certified. GMP stands for Good Manufacturing Practices.

GMP compliant by Swissmedic

The logo indicates that Linnea’s raw material for butylscopolamine is GACP compliant. GACP stands for Good Agricultural Collection Practices.

GACP compliant

LINNEA’S PLANTATION IN AUSTRALIA

Close-up image of Butylscopolamine with the text
An aerial view of farmland. The farmland has crops popping up which represent Duboisia, which butylscopolamine will be extracted from.

Our Butylscopolamine is derived from our plantation of Duboisia plants in Australia.


The Duboisia plant is native only to Australia and to few other regions worldwide.

We are proud to be vertically integrated in our supply chain for this important beneficial ingredient. Linnea has been manufacturing Butylscopolamine since 1985 in our GMP certified facility. We manage our own supply chain and have full traceability for this important ingredient.

Discover our approach

A building that houses Duboisia raw material. The Duboisia will be manufactured into butylscopolamine.
A row of Duboisia plants. The Duboisia will be manufactured by Linnea into butylscopolamine.

Education, Community and Thought Leadership


Linnea goes beyond manufacturing to support our customers, connect with the community, and educate worldwide about the potential therapeutic benefits of our ingredients

Get the latest
Linnea® news